CPAMD8 Antikörper (AA 58-234)
Kurzübersicht für CPAMD8 Antikörper (AA 58-234) (ABIN7875843)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 58-234
-
Verwendungszweck
- CPAMD8 Antibody
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Amino acids R58-D234 from the human protein were used as the immunogen for the CPAMD8 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the CPAMD8 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the CPAMD8 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- CPAMD8 (C3 and PZP-Like, alpha-2-Macroglobulin Domain Containing 8 (CPAMD8))
-
Andere Bezeichnung
- CPAMD8
-
Hintergrund
- CPAMD8 belongs to the complement component-3 (C3) / alpha-2-macroglobulin (A2M) family of proteins, which are involved in innate immunity and damage control. The encoded protein is membrane-associated and proteolytically processed to generate two chains. Mutations in this gene cause a form of anterior segment dysgenesis, a developmental disorder of the eye. By genomic sequence analysis, the CPAMD8 gene is mapped to chromosome 19p13.3-p13.2.
-
UniProt
- Q8IZJ3
Target
-